[Persistent diarrhea]

J A Andrade1, C Moreira, U Fagundes Neto

  • 1Universidade de São Paulo (USP), São Paulo, SP, Brazil.

Jornal De Pediatria
|December 17, 2003
PubMed

Insights

Persistent diarrhea, lasting over 14 days, significantly impacts child health in developing nations. Early intervention and exclusive breastfeeding are key to managing and preventing this severe condition in infants.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Persistent diarrhea affects 3-20% of children under five in developing countries.
  • Defined as diarrhea lasting longer than 14 days, it contributes significantly to infant morbidity and mortality.
  • Etiological agents include Enteropathogenic E. coli (EPEC), Salmonella, Enteroaggregative E. coli (EAEC), Klebisiella, and Cryptosporidium.

Purpose of the Study:

  • To define persistent diarrhea and outline its etiology, clinical aspects, therapy, and prevention.
  • To highlight the multifactorial nature of persistent diarrhea, involving host factors and environmental contamination.
  • To emphasize the importance of prompt treatment and preventive strategies.

Main Methods:

  • Review of existing studies on persistent diarrhea in children under five.
  • Analysis of etiological agents, clinical presentations, and treatment outcomes.
  • Evaluation of preventive measures, particularly breastfeeding.

Main Results:

  • Clinical characteristics of persistent diarrhea are generally consistent across different pathogenic agents.
  • Persistent diarrhea results from a combination of host vulnerabilities and environmental contamination.
  • Oral rehydration therapy and appropriate early feeding are effective in managing most cases.

Conclusions:

  • Prompt treatment of all diarrhea episodes with appropriate follow-up is crucial.
  • Preventive strategies, especially promoting exclusive breastfeeding, are vital for reducing diarrheal disease.
  • Integrated management addressing both treatment and prevention is essential for combating persistent diarrhea.

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Giardiasis01:12

Giardiasis

Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...